Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: Application to HSV-tk/ganciclovir-mediated cytotoxicity

Cellular and Molecular Biology Letters

Volumn 10, Issue 3, 2005, Pages 455-470

  Konopka, Krystyna ^a   Fallah, Basma ^a   Monzon Duller, Jomarie ^a   Overlid, Nathan ^a   Düzgünes, Nejat ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

GeneJammer; HSV tk Gene; Metafectene; Oral Squamous Cell Carcinoma Cells; Serum Inhibition; Transfection

Indexed keywords

BOVINE SERUM ALBUMIN; GANCICLOVIR; GENEJAMMER; LIPOSOME; LUCIFERASE; METAFECTENE; POLYAMINE; RECOMBINANT ENZYME; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUSE; MOUTH CANCER; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; SERUM; SQUAMOUS CELL CARCINOMA;

ANIMALIA; BOVINAE; SIMPLEXVIRUS;

EID: 27644536743     PISSN: 14258153     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Goepfert, H. Squamous cell carcinoma of the head and neck: past progress and future promise. CA Cancer J. Clin. 48 (1998) 195-198.
2. Shillitoe, E.J. Gene therapy for oral cancer: recent progress in research. Oral Oncol. 34 (1998) 157-160.
3. O'Malley, B.W. and Couch, M.E. Gene therapy principles and strategies for head and neck cancer. Adv. Otorhinolaryngol. 56 (2000) 279-288.
4. Xi, S. and Grandis, J.R. Gene therapy for the treatment of oral squamous cell carcinoma, J. Dent. Res. 82 (2003) 11-16.
5. Goebel, E.A., Davidson, B.L., Zabner, J., Graham, S.M. and Kern, J.A. Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas. Ann. Otol. Rhinol. Laryngol. 105 (1996) 562-567.
6. Sewell, D.A., Li, D., Duan, L., Schwartz, M.R. and O'Malley Jr., B.W. Optimizing suicide gene therapy for head and neck cancer. Laryngoscope 107 (1997) 1490-1495.
7. Sewell, D.A., Li, D., Duan, L., Westra, W.H. and O'Malley Jr., B.W. Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer. Arch. Otolaryngol. Head Neck Surg. 123 (1997) 1298-1302.
8. Wang, J.H., Situ, Z.Q., Wu, J.Z. and Liu, B. DNA-liposome complexes transduction of herpes simplex virus thymidine kinase renders human tongue cancer cell line sensitive to ganciclovir in vitro. Chin. J. Dent. Res. 3 (2000) 44-48.
9. Fukui, T., Hayashi, Y., Kagmi, H., Yamamoto, N., Fukuhara, H., Tohnai, I., Ueda, M., Mizuno, M. and Yoshida, J. Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector. Oral Oncol. 37 (2001) 211-215.
10. Fukuhara, H., Hayashi, Y., Yamamoto, N., Fukui, T., Nishikawa, M., Mitsudo, K., Tohnai, I., Ueda, M., Mizuno, M. and J. Yoshida, J. Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell lines. Oral Oncol. 39 (2003) 601-609.
11. O'Malley Jr., B.W., Sewell, D.A., Li, D., Kosai, K., Chen, S.H., Woo, S.L. and Duan, L. The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer. Mol. Endocrinol. 11 (1997) 667-673.
12. Li, D., Duan, L., Jiang, W., Bishop, J., Ralston, R. and O'Malley Jr., B.W. Combination surgery and nonviral interleukin-2 gene therapy for head and neck cancer. Clin. Cancer Res. 5 (1999) 1551-1556.
13. Li, D., Shugert, E., Guo, M., Bishop, J.S. and O'Malley Jr., B.W. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 127 (2001) 1319-1324.
14. Li, D., Zeiders, J.W., Liu, S., Guo, M., Xu, Y., Bishop, J.S. and O'Malley Jr., B.W. Combination nonviral cytokine gene therapy for head and neck cancer. Laryngoscope 111 (2001) 815-820.
15. Day, K.V., Li, D., Liu, S., Guo, M. and O'Malley Jr., B.W. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer. Laryngoscope 111 (2001) 801-806.
16. Gleich, L.L. Gene therapy for head and neck cancer. Laryngoscope 110 (2000) 708-726.
17. Eicher, S.A., Clayman, G.L., Liu, T.J., Shillitoe, E.J., Storthz, K.A., Roth, J.A. and Lotan, R. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model. Clin. Cancer Res. 2 (1996) 1659-1664.
18. Wakasa, T., Inoue, T., Kawai, N., Murakami, J., Kishi, K. and Fukui, K. The combination of ionizing radiation and expression of a wild type p53 gene via recombinant adenovirus induced a prominent tumour suppressing effect in human oral squamous cell carcinoma. Br. J. Radiol. 75 (2002) 657-662.
19. Rocco, J.W., Li, D., Liggett Jr., W.H., Duan, L., Saunders Jr., J.K., Sidransky, D. and O'Malley Jr., B.W. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer. Clin. Cancer Res. 4 (1998) 1697-1704.
20. Rhee, J.G., Li, D., O'Malley Jr., B.W. and Suntharalingam, M. Combination radiation and adenovirus-mediated P16(INK4A) gene therapy in a murine model for head and neck cancer. ORL J. Otorhinolaryngol. Relat. Spec. 65 (2003) 144-154.
21. O'Malley Jr., B.W., Li, D., Buckner, A., Duan, L., Woo, S.L.C. and Pardoll, D.M. Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer. Laryngoscope 109 (1999) 389-395.
22. Higuchi, Y., Asaumi, J., Murakami, J., Wakasa, T., Inoue, T., Kuroda, M., Shibuya, K., Shigehara, H., Kawasaki, S., Fukui, K., Kishi, K. and Hiraki, Y. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines. Oncol. Rep. 9 (2002) 1233-1236.
23. Dilber, M.S., Abedi, M.R., Christensson, B., Björkstrand, B., Kidder, G.M., Naus, C.C.G., Gahrton, G. and Smith, C.I. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res. 57 (1997) 1523-1528.
24. Mesnil, M. and Yamasaki, H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 60 (2000) 3989-3999.
25. Konopka, K., Lee, A., Moser-Kim, N., Saghezchi, S., Kim, A., Lim, A., Suzara, V.V. and Düzgünes, N. Gene transfer to human oral cancer cells via non-viral vectors and HSV-tk/ganciclovir-mediated cytotoxicity; Potential for suicide gene therapy. Gene Ther. Mol. Biol. 8 (2004) 307-318.
26. Pedroso de Lima, M.C., Simões, S., Pires, P., Faneca, H. and Düzgünes, N. Cationic lipid-DNA complexes in gene delivery: From biophysics to biological applications. Adv. Drug Deliv. Rev. 47 (2001) 277-294.
27. Zuber, G., Dauty, E., Nothisen, M., Belguise, P. and Behr, J.-P. Towards synthetic viruses. Adv. Drug Del. Rev. 52 (2001) 245-253.
28. Simões, S., Pires, P., Düzgünes, N. and Pedroso de Lima, M.C. Cationic liposomes as gene transfer vectors: Barriers to successful application in gene therapy. Curr. Opin. Mol. Ther. 1 (1999) 147-157.
29. Zabner, J., Fasbender, A.J., Moninger, T., Poellinger, K.A. and Welsch, M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270 (1995) 18997-19007.
30. Escriou, V., Ciolina, C., Lacroix, F., Byk, G., Scherman, D. and Wils, P. Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lypopolyamine/DNA complexes. Biochim. Biophys. Acta 1368 (1998) 276-288.
31. Zelphati, O., Uyechi, L.S., Barron, L.G. and Szoka, F.C. Jr. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim. Biophys. Acta 1390 (1998) 119-133.
32. Yang, J-P. and Huang, L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. 4 (1997) 950-960.
33. Yang, J-P. and Huang, L. Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther. 5 (1998) 380-387.
34. Audouy, S., Molema, G., de Leij, L. and Hoekstra, D. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability, J. Gene Med. 2 (2000) 465-476.
35. Almofti, M.R., Harashima, H., Shinohara, Y., Almofti, A., Li, W. and Kiwada, H. Lipoplex size determines lipofection efficiency with or without serum. Mol. Membr. Biol. 20 (2003) 35-43.
36. Zhang, Y. and T.J. Anchordoquy, T.J. The role of lipid charge density in the serum stability of cationic lipid/DNA complexes. Biochim. Biophys. Acta 1663 (2004) 143-157.
37. Fields, R.D. and Lancaster, M.V. Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am. Biotechnol. Lab. 11 (1993) 48-50.
38. Konopka, K., Pretzer, E., Felgner, P.L. and Düzgünes, N. Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes. Biochim. Biophys. Acta 1312 (1996) 186-196.
39. Gebhart, C.L. and Kabanov, A.V. Evaluation of polyplexes as gene transfer agents. J. Control. Release 73 (2001) 401-416.
40. Kiefer, K., Clement, J., Garidel, P. and Peschka-Suss, R. Transfection efficiency and cytotoxicity of nonviral gene transfer reagents in human smooth muscle and endothelial cells. Pharm. Res. 21 (2004) 1009-1017.
41. Uchida, E., Mizuguchi, H., Ishii-Watabe, A. and Hayakawa, T. Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol. Pharm. Bull. 25 (2002) 891-897.
42. Faneca, H., Simões, S. and Pedroso de Lima, M.C. Evaluation of lipid-based reagents to mediate intracellular gene delivery. Biochim. Biophys. Acta 1567 (2002) 23-33.
43. Li, S., Tseng, W-C., Beer Stolz, D., Wu, S-P., Watkins, S.C. and Huang, L. Dynamic changes in the characteristics of cationic lipid vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. 6 (1999) 585-594.
44. Tros de Ilarduya, C. and Düzgünes, N. Efficient gene transfer by transferrin lipoplexes in the presence of serum. Biochim. Biophys. Acta 1463 (2000) 333-342.
45. Lewis, J.G., Lin, K.Y., Kothvale, A., Flanagan, W.M., Matteucci, M.D., DePrince, R.B., Mook Jr., R.A., Hendren, R.E. and Wagner, R.W. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA 93 (1996) 3176-3181.
46. Singhal, A. and Huang, L. Gene transfer in mammalian cells using liposomes as carriers, in: Gene Therapeutics: Methods and Applications of Direct Gene Transfer (Wolf, J.A., Ed.) Birkhäuser, Boston, 1994, 118-142.
47. Lian, T. and Ho, R.J.Y. Design and characterization of a novel lipid-DNA complex that resists serum-induced destabilization. J. Pharm. Sci. 92 (2003) 2373-2385.
48. Nchinda, G., Überla, K. and Zschörnig, O. Characterization of cationic lipid DNA transfection complexes differing in susceptibility to serum inhibition. BMC Biotechnol. 2 (2002) 1-10.
49. Sussman, R. Direct DNA delivery into zebrafish embryos employing tissue culture techniques. Genesis 31 (2001) 1-5.
50. Park, J., Ries, J., Gelse, K., Kloss, F., von der Mark, K., Wiltfang, J., Neukam, F.W. and Schneider, H. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther. 10 (2003) 1089-1098.
51. Djurovic, S., Iversen, N., Jeansson, S., Hoover, F. and Christensen, G. Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol. Biotechnol. 28 (2004) 21-32.
52. Iczkowski, K.A., Omara-Opyene, A.K. and Klosel, R. Metafectene is superior to lipofectamine in the transfection of G(s) alpha prostate cancer cells. Mol. Biotechnol. 28 (2004) 97-103.
53. Neumann-Giesen, C., Falkenbach, B., Beicht, P., Claasen, S., Luers, G., Stuermer, C.A., Herzog, V. and Tikkanen, R. Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression. Biochem. J. 378 (2004) 509-518.
54. Larcher, C., Bernhard, D, Schaadt, E., Adler, B., Ausserlechner, M.J., Mitterer, M. and Huemer, H.O. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants. Haematologica 88 (2003) 1324-3135.
55. Taler, M., Shpungin, S., Salem, Y., Malovani, H., Pasder, O. and Nir, U. Fer is a downstream effector of insulin and mediates the activation of signal transducer and activator of transcription 3 in myogenic cells. Mol. Endocrinol. 17 (2003) 1580-1592.
56. Kawai, N., Shimada, M., Kawahara, H., Satoh, N. and Yokosawa, Y. Regulation of ascidian Rel by its alternative splice variant. Eur. J. Biochem. 270 (2003) 4459-4468.
57. Thorwald, M., Schlegel, K.A., Wiltfang, J., Rupprecht, S. and Park, J.H. Experimental pilot study on surface activation of implants with liposomal vectors. Mund-, Kiefer- und Gesichtschirurgie 8 (2004) 250-255.
58. Pope, I.M., Poston, G.J. and Kinsella, A.R. The role of bystander effect in suicide gene therapy. Eur. J. Cancer 33 (1997) 1005-1016.
59. Van Dillen, I.J., Mulder, N.H., Vaalburg, W., de Vries, E.F. and Hospers, G.A. Influence of the bystander effect on HSV-tk/GCV gene therapy. Curr. Gene Ther. 2 (2002) 307-322.
60. Vitiello, L., Bockhold, K., Joshi, P.B. and Worton, R.G. Transfection of cultured myoblasts in high serum concentration with DODAC:DOPE liposomes. Gene Ther. 5 (1998) 1306-1313.
61. Ruponen, M., Honkakoski, P., Tammi, M. and Urtti, A. Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J. Gene Med. 6 (2004) 405-414.
62. Li, W., Ishida, T., Tachibana, R., Almofti, M.R., Wang, X. and Kiwada, H. Cell type-specific gene expression, mediated by TFL-3, a cationic liposomal vector, is controlled by a post-transcription process of delivered plasmid DNA. Int. J. Pharm. 276 (2004) 67-74.